SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS [Yahoo! Finance]
Sera Prognostics, Inc. - Class A (SERA)
Company Research
Source: Yahoo! Finance
health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year ended December 31, 2023 Recent Highlights: Announced that the Data Safety Monitoring Board (DSMB) overseeing Sera's pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs (PRIME) study recommended stopping enrollment due to efficacy, reporting that either of the co-primary endpoints met the stopping criteria for statistical significance at the pre-planned interim analysis. In final stages of preparing manuscript submission to premier medical publications. Working diligently with guideline groups to develop appropriate implementation plans while working toward publication of the PRIME study results. Made continued progress in development of product pipeline and PreTRM ® sample collection and assay enhancements, which will provide simpler, cheaper collection methods and more
Show less
Read more
Impact Snapshot
Event Time:
SERA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SERA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SERA alerts
High impacting Sera Prognostics, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
SERA
News
- Female Health Tech Market Report 2024-2034, Featuring Athena Feminine Technologies, Bloomlife, HeraMED, iSono Health, Minerva Surgical, NUVO, Prelude Fertility, Sera Prognostics, Univfy and TotoHealth [Yahoo! Finance]Yahoo! Finance
- Female Health Tech market is estimated to grow at a CAGR of 9.6% by 2034: Visiongain [Yahoo! Finance]Yahoo! Finance
- Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Sera Prognostics' PreTRM: A Speculative Buy In Women's Health [Seeking Alpha]Seeking Alpha
- Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
SERA
Earnings
- 3/20/24 - In-Line
SERA
Sec Filings
- 4/23/24 - Form ARS
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEF
- SERA's page on the SEC website